Grant Street Asset Management’s Charles River Laboratories CRL Stock Holding History

Grant Street Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-80	Closed	-$23K	–	70
2021 Q1	$23K	Buy	+80	New	+$22.2K	0.01%	150

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Grant Street Asset Management's CRL Position: Q2 2021 in Review

Grant Street Asset Management sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 80 shares — an estimated $23K sold.

Grant Street Asset Management first reported a position in CRL in Q1 2021 and held it in 1 quarter. The position peaked at $23K in Q1 2021. 638 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

Grant Street Asset Management reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
Grant Street Asset Management sold 80 Charles River Laboratories shares in Q2 2021, an estimated $23K.
Grant Street Asset Management first reported a position in Charles River Laboratories in Q1 2021 and held it in 1 quarter.
Grant Street Asset Management's Charles River Laboratories position peaked at $23K in Q1 2021.
638 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.